Overview

• President Donald Trump has confirmed his administration is considering rescheduling marijuana from Schedule I to Schedule III, with a final determination due in the coming weeks.
• Unnamed pro-Trump sources indicate Schedule III is the likely compromise, reflecting a middle path between full legalization and existing federal restrictions.
• Industry leaders say rescheduling would lift heavy IRS 280E tax burdens, expand banking access and attract investors, unlocking growth and new medical research opportunities.
• Public-health experts and law enforcement voices warn that modern high-potency cannabis carries increased cardiac, psychiatric and cognitive risks.
• Cannabis businesses and trade groups have contributed millions to Trump-aligned political organizations and lobbied heavily as the White House, HHS, DEA and Justice Department advance formal rulemaking.